Nebraska and Stem Cells

Good news for fans of embryonic stem cell research — according to the Associated Press, the board of regents at the University of Nebraska voted down the proposal, which I wrote about yesterday, to impose Bush-esque restrictions on the stem cell lines available for research. To quote from the Associated Press:

LINCOLN, Neb. — The University of Nebraska’s governing board on Friday voted down a proposal to restrict the school’s rules governing embryonic stem-cell research beyond what the federal government allows.

The eight-member Board of Regents voted 4-4, defeating the resolution that would have restricted stem cell experiments to cell lines approved under President George W. Bush. President Barack Obama removed government funding restrictions on new stem-cell lines earlier this year.

A majority of votes was needed for a proposal to pass.

I’m still not psyched about a state law passed 20 months ago that prohibits state funds from being used to create or destroy embryos for research, but I’m very relieved that the University is not going to enact tougher limits on research than are called for either by state or federal law.

Catherine Price

Catherine Price (www.catherine-price.com) was diagnosed with Type 1 diabetes when she was 22 years old. She has written for publications including The Best American Science Catherine Price is a professional journalist who was diagnosed with Type 1 diabetes when she was 22 years old. Her work has been featured in publications including The Best American Science Writing, The New York Times, Popular Science, The Los Angeles Times, The San Francisco Chronicle, The Washington Post Magazine, Salon, Slate, Men’s Journal, Health Magazine, The Oprah Magazine, and Outside, among others. A graduate of Yale and UC Berkeley’s Graduate School of Journalism

View Author Blog

Catherine Price

Catherine Price was diagnosed with Type 1 diabetes when she was 22 years old. She has written for publications including The Best American Science Catherine Price is a professional journalist who was diagnosed with Type 1 diabetes when she was 22 years old. Her work has been featured in publications including The Best American Science Writing, The New York Times, Popular Science, The Los Angeles Times, The San Francisco Chronicle, The Washington Post Magazine, Salon, Slate, Men’s Journal, Health Magazine, The Oprah Magazine, and Outside, among others. A graduate of Yale and UC Berkeley’s Graduate School of Journalism